FGFR2 and urothelial carcinoma: Potentially actionable genomic alterations included FGFR2/3, ERBB2, and PIK3CA, and alteration frequencies of these genes in resected MIBC from IMvigor010 were similar to the prevalence in advanced-stage urothelial carcinoma based on the FoundationCORETM dataset.